Jaguar Health, Inc. announced that its founder, president, and CEO, Lisa Conte, will present virtually and meet with investors at the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024. The presentation will be available on-demand starting September 9th. Jaguar Health is a commercial-stage pharmaceuticals company focusing on plant-derived medicines for gastrointestinal conditions in humans and animals, with key subsidiaries like Napo Pharmaceuticals and Napo Therapeutics, and a joint venture, Magdalena Biosciences, for mental health indications.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
Jaguar Health, Inc. announced that its founder, president, and CEO, Lisa Conte, will present virtually and meet with investors at the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024. The presentation will be available on-demand starting September 9th. Jaguar Health is a commercial-stage pharmaceuticals company focusing on plant-derived medicines for gastrointestinal conditions in humans and animals, with key subsidiaries like Napo Pharmaceuticals and Napo Therapeutics, and a joint venture, Magdalena Biosciences, for mental health indications.